Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe NIH transition announcement about terminology changes and related updates is no longer displayed in the site-wide banner.SummaryDifference1%

- Check20 days agoChange DetectedThe site revision label in the footer changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces NIH website changes and says that some NIH content will use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with a link to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2, while the study page still displays a 403 Forbidden error.SummaryDifference0.3%

- Check41 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows a new revision tag (v3.7.0) and a large set of study-related terms and keywords were removed, indicating a restructuring of the trial's metadata and indexing.SummaryDifference17%

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.